Tissue Specific Targeting
Tissue Specific Targeting - Related Videos
06:37
Ubiquitous and Tissue-specific RNA Targeting in Drosophila Melanogaster using CRISPR/CasRx
0 Views •
Cited by 7 •
2021
This article outlines a detailed protocol for using the RNA-targeting Cas13D enzyme (RfxCas13D) in flies.
07:36
Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
0 Views •
Cited by 1 •
2020
Here we present a protocol to study the in vivo localization of antibodies in mice tumor xenograft models.
09:49
Antigen Specific In Vivo Killing Assay using CFSE Labeled Target Cells
0 Views •
Cited by 39 •
2010
Many infections elicit a strong CTL response, but occasionally, the quantity of responding cells does not correlate to control of the pathogen1. One measure of CTL quality is their ability to kill specifically2. CFSE labeling of target cells can be used to investigate this CTL response quality in vivo3,4.
11:19
Genome-wide Analysis using ChIP to Identify Isoform-specific Gene Targets
0 Views •
Cited by 13 •
2010
Here we are presenting a chromatin immunoprecipitation (ChIP) procedure for genome-wide location analysis of protein isoforms that differ in a histone-binding domain. We are applying it to ChIP-Seq analysis to identify the targets of the KDM5A/JARID1A/RBP2 histone demethylase.
04:39
Quantitative Dot Blot to Estimate Target Proteins in a Tissue Lysate
0 Views •
2025
This video demonstrates a quantitative dot blot, or QDB, technique for the absolute quantification of proteins of interest in a tissue sample. The proteins in the sample are immobilized on the nitrocellulose membrane inside the wells of a QDB plate. Utilizing target protein-specific antibodies labeled with a peroxidase enzyme, a chemiluminescent substrate is oxidized to produce light, which is measured to determine the protein concentration of the sample.
FAQs
These features provide different biological cues for directing therapeutic or immune materials. Tissue-specific receptors can support selective molecular binding and cellular uptake, while vascular barriers regulate transport into a tissue. Extracellular matrix characteristics can further influence retention or movement within the target site. Designing around one or more of these cues helps align delivery with the biology of the selected tissue.
Inflammatory signals can identify tissues undergoing infection-related immune activity and provide localized cues for delivery or immune modulation. Incorporating these signals into a targeting strategy may help concentrate an intervention where host responses and pathogen activity are occurring. This is especially relevant when researchers want to influence local immunity without producing the same degree of activity throughout the body.
Concentrating an antimicrobial agent or immunomodulator at the relevant tissue can strengthen activity where it is needed while limiting exposure elsewhere. This distribution pattern may reduce off-target effects and systemic toxicity compared with uniform delivery. In infection research, localized accumulation also supports more focused control of pathogen-associated processes and tissue-level immune responses.
A design begins by identifying biological features that distinguish the intended tissue, such as receptors, vascular barriers, extracellular matrix properties, or inflammatory signals. Researchers can then match those features with an appropriate delivery vehicle or molecular ligand. The resulting strategy is intended to promote tissue accumulation and cellular uptake while aligning the intervention with the local disease or immune environment.
This approach is useful when infection is concentrated in a defined organ or tissue and treatment would benefit from local enrichment. Targeting can direct antimicrobial agents toward infected sites rather than distributing them uniformly. Such localization may improve treatment precision and limit systemic toxicity, making the strategy relevant to studies of infected organs and host-pathogen interactions.
Vaccines or immunomodulators can be directed toward tissues where a local immune response is most relevant. Tissue selection may help shape immunity at the site of infection or exposure while reducing unnecessary systemic activity. This supports research into more precise immune interventions, including approaches designed to improve protection and clarify how local immune environments influence infection outcomes.